MultiBagger Alerts

[ProfitScout]

$SBFM is making important contributions to the vital medical issues of Coronavirus and Cancer treatments today. Get the latest update direct from the CEO in this new presentation:

CEO of Sunshine Biopharma, Dr. Steve Slilaty, is Featured on The Stock Day Podcast
Click here:
https://sunshinebiopharma.com/ceo-of-sunshine-biopharma-dr-steve-slilaty-is-featured-on-the-stock-day-podcast/

About Sunshine Biopharma

In addition, to working on the development of a treatment for COVID-19, Sunshine Biopharma is engaged in the development Adva-27a, a unique anticancer compound. Tests conducted to date have demonstrated the effectiveness of Adva-27a at destroying Multidrug Resistant Cancer Cells, including Pancreatic Cancer cells, Small-Cell Lung Cancer cells, Breast Cancer cells, and Uterine Sarcoma cells. Clinical trials for Pancreatic Cancer indication are planned to be conducted at McGill University's Jewish General Hospital in Montreal, Canada. Sunshine Biopharma is owner of all patents and intellectual property pertaining to Adva-27a.